139 related articles for article (PubMed ID: 25523354)
1. Parental age and Neurofibromatosis Type 1: a report from the NF1 Patient Registry Initiative.
Liu Q; Zoellner N; Gutmann DH; Johnson KJ
Fam Cancer; 2015 Jun; 14(2):317-24. PubMed ID: 25523354
[TBL] [Abstract][Full Text] [Related]
2. The effect of parental age on the presence of de novo mutations - Lessons from neurofibromatosis type I.
Dubov T; Toledano-Alhadef H; Bokstein F; Constantini S; Ben-Shachar S
Mol Genet Genomic Med; 2016 Jul; 4(4):480-6. PubMed ID: 27468422
[TBL] [Abstract][Full Text] [Related]
3. Validity of participant-reported diagnoses in an online patient registry: a report from the NF1 Patient Registry Initiative.
Sharkey EK; Zoellner NL; Abadin S; Gutmann DH; Johnson KJ
Contemp Clin Trials; 2015 Jan; 40():212-7. PubMed ID: 25533730
[TBL] [Abstract][Full Text] [Related]
4. Associations between allergic conditions and pediatric brain tumors in Neurofibromatosis type 1.
Porcelli B; Zoellner NL; Abadin SS; Gutmann DH; Johnson KJ
Fam Cancer; 2016 Apr; 15(2):301-8. PubMed ID: 26666764
[TBL] [Abstract][Full Text] [Related]
5. Racial/Ethnic Differences in Pediatric Brain Tumor Diagnoses in Patients with Neurofibromatosis Type 1.
Abadin SS; Zoellner NL; Schaeffer M; Porcelli B; Gutmann DH; Johnson KJ
J Pediatr; 2015 Sep; 167(3):613-20.e1-2. PubMed ID: 26028287
[TBL] [Abstract][Full Text] [Related]
6. The importance of advanced parental age in the origin of neurofibromatosis type 1.
Snajderova M; Riccardi VM; Petrak B; Zemkova D; Zapletalova J; Mardesic T; Petrakova A; Lanska V; Marikova T; Bendova S; Havlovicova M; Kaluzova M
Am J Med Genet A; 2012 Mar; 158A(3):519-23. PubMed ID: 22302476
[TBL] [Abstract][Full Text] [Related]
7. Peri-gestational risk factors for pediatric brain tumors in Neurofibromatosis Type 1.
Johnson KJ; Zoellner NL; Gutmann DH
Cancer Epidemiol; 2016 Jun; 42():53-9. PubMed ID: 27018750
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of preimplantation genetic diagnosis in neurofibromatosis type 1.
Merker VL; Murphy TP; Hughes JB; Muzikansky A; Hughes MR; Souter I; Plotkin SR
Fertil Steril; 2015 Mar; 103(3):761-8.e1. PubMed ID: 25557241
[TBL] [Abstract][Full Text] [Related]
9. Malignant and benign tumors in patients with neurofibromatosis type 1 in a defined Swedish population.
Zöller ME; Rembeck B; Odén A; Samuelsson M; Angervall L
Cancer; 1997 Jun; 79(11):2125-31. PubMed ID: 9179058
[TBL] [Abstract][Full Text] [Related]
10. Paternal age and sporadic neurofibromatosis 1: a case-control study and consideration of the methodologic issues.
Bunin GR; Needle M; Riccardi VM
Genet Epidemiol; 1997; 14(5):507-16. PubMed ID: 9358268
[TBL] [Abstract][Full Text] [Related]
11. The effect of parental age on NF1 patients in Turkey.
Sharafi P; Anlar B; Ersoy-Evans S; Varan A; Yılmaz OF; Turan M; Ayter S
J Community Genet; 2018 Jul; 9(3):227-232. PubMed ID: 29143198
[TBL] [Abstract][Full Text] [Related]
12. Distinctive Cancer Associations in Patients With Neurofibromatosis Type 1.
Uusitalo E; Rantanen M; Kallionpää RA; Pöyhönen M; Leppävirta J; Ylä-Outinen H; Riccardi VM; Pukkala E; Pitkäniemi J; Peltonen S; Peltonen J
J Clin Oncol; 2016 Jun; 34(17):1978-86. PubMed ID: 26926675
[TBL] [Abstract][Full Text] [Related]
13. Mortality in neurofibromatosis 1: an analysis using U.S. death certificates.
Rasmussen SA; Yang Q; Friedman JM
Am J Hum Genet; 2001 May; 68(5):1110-8. PubMed ID: 11283797
[TBL] [Abstract][Full Text] [Related]
14. Birth Characteristics Among Children Diagnosed with Neurofibromatosis Type 1 and Tuberous Sclerosis.
Tettamanti G; Mogensen H; Kampitsi CE; Nordgren A; Feychting M
J Pediatr; 2021 Dec; 239():200-205.e2. PubMed ID: 34390698
[TBL] [Abstract][Full Text] [Related]
15. School performance of children with neurofibromatosis 1: a nationwide population-based study.
Doser K; Belmonte F; Andersen KK; Østergaard JR; Hove H; Handrup MM; Ejerskov C; Mulvihill JJ; Winther JF; Kenborg L
Eur J Hum Genet; 2022 Dec; 30(12):1405-1412. PubMed ID: 35859011
[TBL] [Abstract][Full Text] [Related]
16. Neurofibromatosis type 1 and childhood cancer.
Matsui I; Tanimura M; Kobayashi N; Sawada T; Nagahara N; Akatsuka J
Cancer; 1993 Nov; 72(9):2746-54. PubMed ID: 8402499
[TBL] [Abstract][Full Text] [Related]
17. Epileptic seizures in neurofibromatosis type 1 are related to intracranial tumors but not to neurofibromatosis bright objects.
Hsieh HY; Fung HC; Wang CJ; Chin SC; Wu T
Seizure; 2011 Oct; 20(8):606-11. PubMed ID: 21621428
[TBL] [Abstract][Full Text] [Related]
18. Increased Risk of Cerebrovascular Disease Among Patients With Neurofibromatosis Type 1: Population-Based Approach.
Terry AR; Jordan JT; Schwamm L; Plotkin SR
Stroke; 2016 Jan; 47(1):60-5. PubMed ID: 26645253
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer in neurofibromatosis type 1: overrepresentation of unfavourable prognostic factors.
Uusitalo E; Kallionpää RA; Kurki S; Rantanen M; Pitkäniemi J; Kronqvist P; Härkönen P; Huovinen R; Carpen O; Pöyhönen M; Peltonen S; Peltonen J
Br J Cancer; 2017 Jan; 116(2):211-217. PubMed ID: 27931045
[TBL] [Abstract][Full Text] [Related]
20. Analysis of intrafamilial phenotypic variation in neurofibromatosis 1 (NF1).
Szudek J; Joe H; Friedman JM
Genet Epidemiol; 2002 Aug; 23(2):150-64. PubMed ID: 12214308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
